tm logo

Monitor this mark

View On USPTO

ODAWNLY
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 18 Jun 2024

Last Applicant/ Owned by

Sage Therapeutics, Inc.

55 Cambridge Parkway

Cambridge

MA

02142

Serial Number

97485027 filed on 01st Jul 2022

Registration Number

N/A

Correspondent Address

Steven A. Abreu

Steven A. Abreu SUNSTEIN LLP

BOSTON, MA 02110

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ODAWNLY

Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97485027

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4362/2040

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
25th Nov 2024SOU TEAS EXTENSION RECEIVED
18th Jun 2024SOU EXTENSION 2 FILED
18th Jun 2024SOU EXTENSION 2 GRANTED
18th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18th Jun 2024SOU TEAS EXTENSION RECEIVED
07th Dec 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05th Dec 2023SOU EXTENSION 1 GRANTED
05th Dec 2023SOU EXTENSION 1 FILED
05th Dec 2023SOU TEAS EXTENSION RECEIVED
20th Jun 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT